3082
J. K. Nelson et al. / Tetrahedron Letters 49 (2008) 3078–3082
9. Diana, G.; Volkots, D.; Nitz, T. J.; Bailey, T. R.; Long, M. A.;
Vescio, N.; Aldous, S.; Pevear, D. C.; Dutko, F. J.. J. Med. Chem.
1994, 37, 2421–2436.
10. Dannhardt, G.; Kiefer, W.; Lambrecht, G.; Laufer, S.; Mutschler, E.;
Schweiger, J.; Striegel, H. G. Eur. J. Med. Chem. 1995, 30, 839–850.
11. McKenna, J. I.; Schlicksupp, L.; Natale, N. R.; Maryanoff, B. E.;
Flaim, S. F.; Willett, R. D. J. Med. Chem. 1988, 31, 473–476.
12. Natale, N. R.; Niou, C.-S. Tetrahedron Lett. 1984, 3943–3946.
13. Natale, N. R.; Mirzaei, Y. R. Org. Prep. Proced. Int. 1993, 25, 515–
556.
25. Beak, P.; Reitz, D. B. Chem. Rev. 1978, 78, 275–316.
26. Stol, M.; Snelders, D. J. M.; de Pater, J. J. M.; van Klink, G. P. M.;
Kooijman, H.; Spek, A. L.; van Koten, G. Organometallics 2005, 24,
743–749.
27. (a) Lin, B.; Whalen, D. L. J. Org. Chem. 1994, 59, 1638–1641; (b)
Sankawa, U.; Sato, T. Tetrahedron Lett. 1978, 19, 981–984; (c) Biggs,
J.; Chapman, N. B.; Wray, V. J. Chem. Soc. B 1971, 71.
28. (a) Mukerji, I.; Wayda, A. L.; Dabbagh, G.; Bertz, S. H. Angew.
Chem. 1986, 98, 756–757; (b) Lipshutz, B. H.; Moretti, R.; Crow, R.
Org. Synth. 1990, 69, 80–88.
14. Hantzsch, A. Justus Liebigs Ann. Chem. 1882, 215, 1.
15. Zamponi, G. W.; Stotz, S. C.; Staples, R. J.; Andro, T. M.; Nelson, J.
K.; Hulubei, V.; Blumenfeld, A.; Natale, N. R. J. Med. Chem. 2003,
46, 87–96.
29. This effect has been noted elsewhere: (a) House, H. O. J. Am. Chem.
Soc. 1955, 77, 3070. Conversion of styrene oxide to phenyl acetalde-
hyde has been optimized (b) Kim, Jong Dae; Cha, Jin Soon Taehan
Hwahakhoe Chi 1983, 27, 73–75.
16. Mueller, G. In Chemogenomics in Drug Discovery; Kubinyi, H.,
Mueller, G., Eds.; John Wiley, 2004; p 19.
17. Triggle, D. J. Cell. Mol. Neurobiol. 2003, 23, 293–303.
18. Nobili, S.; Landini, I.; Giglioni, B.; Mini, E. Curr. Drug. Targets 2006,
7, 861–879.
30. Unpublished result. No starting material or desired product is
recovered on attempted oxidation with the Dess–Martin periodinane,
whereas the secondary alcohol 3b is readily oxidized in high yields,
see: Nelson, J. K.; Burkhart, D. J.; McKenzie, A.; Natale, N. R.
Synlett 2003, 2213–2215.
19. Voigt, B.; Coburger, C.; Monar, J.; Hilgroth, A. Bioorg. Med. Chem.
2007, 15, 5110–5113.
31. Ramirez, A.; Collum, D. B. J. Am. Chem. Soc. 1999, 121, 11114–
11121.
20. Zuidema, G. D.; Cook, P. L.; Van Zyl, G. J. Am. Chem. Soc. 1953, 75,
294–296.
32. The isoxazole anions cited below did not react with epoxides: (a)
Burkhart, D. J.; Zhou, P.; Blumenfeld, A.; Twamley, B.; Natale, N.
R. Tetrahedron 2001, 57, 8039–8046; (b) Han, X.; Li, C.; Rider, K. C.;
Blumenfeld, A.; Twamley, B.; Natale, N. R. Tetrahedron Lett. 2002,
43, 7673–7677.
21. (a) Natale, N. R.; McKenna, J. I.; Niou, C.-S.; Borth, M.; Hope, H. J.
Org. Chem. 1985, 50, 5660–5666; for an improved procedure for the
preparation of unhindered isoxazolyl–oxazolines, see: (b) Zhou, P.;
Blubaum, J. E.; Burns, C. T.; Natale, N. R. Tetrahedron Lett. 1997,
38, 7019–7020.
33. de Bruin, T. J. M.; Magna, L.; Raybaud, P.; Toulhoat, H.
Organometallics 2003, 22, 3404–3413.
22. Gawley, R. E.; Hart, G. C.; Bartolotti, L. J. J. Org. Chem. 1989, 54,
175–181.
34. Just such a g2 coordination has been observed in the solid state: (a)
Dohmeier, C.; Baum, E.; Ecker, A.; Koppe, R.; Schnockel, H.
Organometallics 1996, 15, 4702–4706; (b) Haslam, E. Shikimic
Acid Metabolism and Metabolites; John Wiley & Sons: New York,
1993.
´
23. Ramirez, A.; Lobkovsky, E.; Collum, D. B. J. Am. Chem. Soc. 2003,
125, 15376–15387.
24. Gawley, R. E.; Hart, G.; Goicoechea-Pappas, M.; Smith, A. L. J.
Org. Chem. 1986, 51, 3076–3078.